Ternary Alloy PtWMn as a Mn Nanoreservoir for High-Field MRI Monitoring and Highly Selective Ferroptosis Therapy.
Guoqiang GuanCheng ZhangHuiyi LiuYoujuan WangZhe DongChang LuBin NanRenye YueXia YinXiao-Bing ZhangGuosheng SongPublished in: Angewandte Chemie (International ed. in English) (2022)
Ferroptosis exhibits potential to damage drug-resistant cancer cells. However, it is still restricted with the "off-target" toxicity from the undesirable leakage of metal ions from ferroptosis agents, and the lack of reliable imaging for monitoring the ferroptosis process in living systems. Herein, we develop a novel ternary alloy PtWMn nanocube as a Mn reservoir, and further design a microenvironment-triggered nanoplatform that can accurately release Mn ions within the tumor to increase reactive oxygen species (ROS) generation, produce O 2 and consume excess glutathione for synergistically enhancing nonferrous ferroptosis. Moreover, this nanoplatform exerts a responsive signal in high-field magnetic resonance imaging (MRI), which enables the real-time report of Mn release and the monitoring of ferroptosis initiation through the signal changes of T 1 -/T 2 -MRI. Thus, our nanoplatform provides a novel strategy to store, deliver and precisely release Mn ions for MRI-guided high-specificity ferroptosis therapy.
Keyphrases
- multidrug resistant
- drug resistant
- cell death
- magnetic resonance imaging
- acinetobacter baumannii
- contrast enhanced
- reactive oxygen species
- diffusion weighted imaging
- cancer therapy
- photodynamic therapy
- room temperature
- metal organic framework
- oxidative stress
- computed tomography
- transition metal
- quantum dots
- drug release
- high resolution
- magnetic resonance
- stem cells
- risk assessment
- dna damage
- pseudomonas aeruginosa
- cell therapy
- climate change
- reduced graphene oxide
- mass spectrometry
- visible light
- replacement therapy